We assessed the seroprevalence of antibodies to Trypanosoma cruzi among pregnant Hispanic women in Houston. Sera from 2,107 Hispanic and 1,658 non-Hispanic subjects were tested by ELISA for the presence of antibodies to T. cruzi. Twenty-two (0.6%) of 3,765 subjects had sera that were reactive. Seroreactivity was confirmed by hemagglutination assay. Eleven subjects had reactive sera, giving a confirmed seroprevalence of 0.3% (95% CI, 0 -1%). Nine sera from Hispanic and two from non-Hispanic women were positive by hemagglutination assay, for a prevalence of 0.4% and 0.1%, respectively, during pregnancy. On the basis of these seroreactivity data, transplacental transmission of T. cruzi could occur in the continental United States. Screening for antibodies to T. cruzi during pregnancy would provide the potential for early intervention in congenital Chagas' disease.
American trypanosomiasis is an anthropozoonosis caused by been published previously [13, 23 -28] , but none of these have evaluated seroprevalence during pregnancy. Trypanosoma cruzi. The area of endemicity for Chagas' disease extends from Mexico south to Argentina and Chile. An esti-
The purpose of this investigation was to assess the prevalence of T. cruzi infection among pregnant Hispanic women mated 16 -18 million persons in Latin America are infected with the parasite [1, 2] . Humans acquire infection when the in Houston. We found that these women have substantial risk for Chagas' disease. Our findings demonstrate the importance biting site or mucous membranes are contaminated by infected feces of the insect vector, through transfusion of contaminated of testing for T. cruzi antibodies among Latin American pregnant women, since the parasite may be transmitted to newborn blood, transplacentally, or accidentally in laboratories by handling the parasite or contaminated vectors.
infants. Screening for detection of chronically infected pregnant women is crucial for early diagnosis and treatment of infants Named after Dr. Carlos Ribeiro Justiniano das Chagas, a Brazilian physician who described the disease in 1911, chronic with congenital T. cruzi infection. infection due to T. cruzi can cause serious heart disease and gastrointestinal pathology. Since the manifestations of chronic Methods Chagas' disease may not become evident until decades after acquisition of the parasite, screening programs are helpful in Study population. A cross-sectional design was selected to determine the seroprevalence of antibodies to T. cruzi among assessing the population at risk. In Latin America, the seroprevalence of antibodies to T. cruzi during pregnancy ranges from pregnant Hispanic women. The study population consisted of 2,107 Hispanic and 1,658 non-Hispanic pregnant women living 2% to 51% [3 -8] . Between 1% and 4% of infants acquire T. cruzi infection transplacentally from their chronically inin Houston who sought prenatal care at one of seven City of Houston Department of Health and Human Services clinics fected mothers [3] . Cases in humans [2, 9 -12] and the sylvatic cycle [13 -22] Characteristics of the study population. The survey is a representative probability sample of 2,107 Hispanic and 1,658 The plate was read in a plate reader (MR 5000; Dynatech, Alexandria, VA) at 450 nm. A positive reaction was defined, non-Hispanic pregnant women attending Houston City Health Clinics between 1993 and 1996. Seventy-nine percent of the according to the manufacturer's instructions, as the mean optical density (OD) of duplicate negative control sera plus 0.250. samples tested were collected in 1996. The ethnic distribution of these 3,765 pregnant women was 56% Hispanic, 15.4% Positive and negative control sera, included in duplicate in each assay, consistently had OD readings §0.4 and £0.028, white, and 28.6% black. Subjects' ages ranged from 13 to 44 years (mean, 25 years). respectively. In prelicensure testing, the sensitivity and specificity of the Hemagen Chagas' Kit as provided by the manufacSeroprevalence data. Twenty-two sera (0.6%) were positive for antibody to T. cruzi by ELISA. Thirteen of these were turer were 100% and 98.7%, respectively. All samples were tested with kits with the two lot numbers 612175 or 8WA2101.
from Hispanic and nine from non-Hispanic women (table 1) . The ethnic distribution for women with sera reactive by ELISA Sera initially testing positive by ELISA underwent retesting. The ELISA was considered a screening modality for seroreacdid not differ significantly from that of those with negative samples. Similarly, there was no significant difference in tivity to T. cruzi.
The Hemagen Chagas' Kit (hemagglutination [HA] method), ELISA seropositivity for T. cruzi between women õ20 or §20 years old. provided by Hemagen Diagnostics, was used for confirmation of seroreactivity of sera that were positive by ELISA. The HA Figure 1 depicts the distribution of OD values for sera from Hispanic and non-Hispanic women grouped according to negaassay is designed for the qualitative detection and semiquantitative measurement of circulating IgG and IgM antibodies to tivity or positivity by ELISA. The difference between the mean OD for reactive sera from Hispanics (0.875; range, 0.308 -T. cruzi. Serial twofold serum dilutions from 1:26 to 1:832 were used as a semiquantitative measurement of T. cruzi anti-1.921) and that from non-Hispanics (0.352; range 0.289 -0.453) was significant (P õ .0001). The mean OD for the bodies. Sera were diluted in physiological saline and incubated at room temperature for 90 minutes with red blood cells sensi-3,743 negative samples was 0.0838 (range, 0.004 -0.308). Specimens that were initially positive were subjected to retized with antigens extracted from cultured T. cruzi. A well was considered positive if the cell deposit was less than half peat ELISA and testing by HA. All 22 sera that were initially ELISA-reactive were positive on retesting. Eleven of 22 subthe size of the negative control and the medium was turbid. Kits with lot number 7RK200 were used for all HA assays. A jects screened as positive by ELISA were confirmed as positive by HA (table 2) . The overall prevalence of seropositivity within positive HA test was considered definitive for the presence of antibodies to T. cruzi in sera.
the study population was 0.3% (95% CI, 0 -1%). The prevalence among Hispanic and non-Hispanic pregnant women was The rationale for use of ELISA for initial testing was based on its being used to screen infants at risk for congenital Chagas' 0.4% and 0.1%, respectively (x 2 , P Å .073). The rate ratio for T. cruzi infection was 3.5 times higher disease in regions of endemicity, such as Argentina. Expense often prohibits the use of additional testing, and the ELISA (95% CI, 0.8 -16.5 times higher) among Hispanics than among non-Hispanics. The mean age for Hispanic pregnant women cutoff OD may be used to determine the need for treatment. No true ''gold standard'' serologic test for Chagas' disease has with confirmed antibodies to T. cruzi by HA was 26 years (range, 18 -33 years). The difference between mean HA values been identified. We chose to use a second method of testing, based on a different principle, for confirmatory testing. HA for Hispanics and non-Hispanics was significant (P Å .022, t test for independent samples). A positive correlation was testing offered the advantage that only a small additional volume of serum was required.
observed between the mean OD by ELISA and the reciprocal HA titer (r Å .91, P Å .001) (figure 2). The positive predictive Statistical analysis. Sample sizes were calculated by use of Epi-Info version 6.0 (CDC -WHO, Geneva, Switzerland, value for ELISA was 69% (9/13) in Hispanic and 22% (2/9) in non-Hispanic women. 1994). Calculations were based on an estimated seroprevalence of T. cruzi antibodies ranging from 0.3% to 1.0% in the HisResults from previous testing for hepatitis B surface antigen were available for all 3,765 subjects. Ten had detectable hepatipanic and 0.01% in the non-Hispanic study population. Data analysis was done with the SPSS version 7.0 (SPSS, Chicago) tis B surface antigen, giving an overall seroprevalence of hepatitis B virus infection of 0.3%. Eight of these subjects were software package. Statistical significance for continuous variables was determined by use of the t test. Categorical variables non-Hispanic and two were Hispanic (P Å .062 from Hispanic (open bars) and non-Hispanic (shaded bars) subjects.
/ 9c68$$ju26 05-11-99 12:29:54 cida UC: CID nant women, the seroprevalence rates for Chagas' disease are three times higher than those described in blood bank donors. Burkholder et al. [13] found a similar overall seroprevalence among Rio Grande Valley residents of 0.8%, confirmed by the Centers for Disease Control and Prevention by use of indirect HA and complement fixation assays. We assumed our subjects would have had exposure in Latin America, but it is possible that infection could have resulted from indigenous or blood transfusion -related transmission. Assessment of risk factors for T. cruzi infection was not possible in the present investigation, since the demographic data were assessed retrospectively. Information such as country of origin, travel history to an area of endemicity, history of Chagas' disease or blood transfusion in Latin America, or having contact with the reduviid bug was not available. The two black subjects with sera reactive by HA could have immigrated from Latin America, could have had other risk factors for results. They were two of only three subjects with reciprocal HA titers of 26 and were among those with the lowest ODs by ELISA. Because of our study design, it was not possible to perform subsequent testing or to test infant sera. T. cruzi. Four of the five indigenous cases of Chagas' disease described in this country have been reported from persons livFrom a recent report of the US Bureau of the Census [31], one can estimate the overall prevalence of T. cruzi -chronically ing in Texas [9 -12] . The prevalence of infected vectors and of infection in the animal reservoir have been studied in Texas, infected Hispanic pregnant women in Texas. A total of 251,941 births were reported for this population in 1992, including all and the impact of Central and South American immigration patterns on T. cruzi infection has been noted [13, 17, 21] .
Hispanic races (whites and blacks) and immigrants from Mexico and South and Central America. On the basis of an overall However, little is known concerning the seroprevalence of antibodies to T. cruzi in residents of Texas [29] .
seroprevalence of 0.4%, the number of chronically infected pregnant Hispanic women would be Ç1,000. Because 1% -4% The risk of transplacental transmission of T. cruzi was recognized at the beginning of the 20th century. Extensive studies of infants born to these chronically infected pregnant women would be expected to acquire infection, Ç10 -40 cases of of pregnant women done in countries in which Chagas' disease is endemic found a high prevalence of T. cruzi seropositivity T. cruzi congenital infection could occur annually in Texas. A population projection for the state of Texas estimates that the in this population, especially in Bolivia, Brazil, and Paraguay. Reports from these countries reveal that 25% -51% of pregnant Hispanic population will increase from 20,039,000 in the year 2000 to 22,850,000 by the year 2015. Thus, a proportional women are chronically infected with T. cruzi [1] . No data are available from the United States, and no cases of congenital increase in T. cruzi -infected persons likely will be seen. Awareness of the seroprevalence of Chagas' disease in our infection have been described. However, most neonates born with T. cruzi infection are asymptomatic or have subtle sympselected Latin American population will be useful in directing a more effective diagnostic approach to this opportunistic and toms that make the diagnosis difficult, especially if the serologic status of the mother is not known [3, 5, 6, 27] . When potentially fatal infection [30] . Public health authorities should assess whether screening of certain high-risk pregnant women T. cruzi is acquired acutely during pregnancy, the risk of transmission to the fetus is Ç70% [27]. The rate of transplacental for antibodies to T. cruzi should be undertaken routinely. It is of interest that perinatal screening is done routinely for diseases transmission during chronic disease ranges from 1% to 4% [3] . The mother usually is asymptomatic at the time of delivery such as hepatitis B, for which the race-adjusted prevalence of hepatitis B surface antigen positivity among parturient women [3] . However, reactivation of parasitemia can occur during the third trimester, possibly because of decreased cell-mediated is estimated to be 0.57% [32] . Similarly, some states perform routine screening for congenital toxoplasmosis, which has an immunity. Coinfection with HIV increases the risk of perinatal transmission and is associated with high morbidity for both incidence of Ç1 in 8,000 births [33] . Chagas' disease shares with hepatitis B and toxoplasmosis the availability of effective mother and infant [3, 7, 8, 30] .
To our knowledge, this investigation is the first report of the treatment when the diagnosis is established early in life. The overall efficacy of benznidazole is 50% within the first 6 seroprevalence of T. cruzi antibodies among pregnant women in the United States. Our data show that among Hispanic pregmonths of life.
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